B. Fisher

7.0k total citations · 4 hit papers
17 papers, 5.2k citations indexed

About

B. Fisher is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, B. Fisher has authored 17 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in B. Fisher's work include Breast Cancer Treatment Studies (8 papers), BRCA gene mutations in cancer (5 papers) and Breast Lesions and Carcinomas (5 papers). B. Fisher is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), BRCA gene mutations in cancer (5 papers) and Breast Lesions and Carcinomas (5 papers). B. Fisher collaborates with scholars based in United States. B. Fisher's co-authors include Norman Wolmark, Carol Redmond, D. Lawrence Wickerham, E. Mamounas, Jennifer Bryant, E R Fisher, Walter M. Cronin, Joseph P. Costantino, Edwin R. Fisher and N V Dimitrov and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

B. Fisher

16 papers receiving 5.0k citations

Hit Papers

A Randomized Clinical Trial Evaluating Tamoxifen in the T... 1988 2026 2000 2013 1989 2001 1994 1988 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Fisher United States 12 3.0k 2.4k 1.4k 1.3k 1.2k 17 5.2k
S. Ashley United Kingdom 39 2.6k 0.9× 1.3k 0.6× 1.3k 0.9× 701 0.5× 933 0.8× 80 6.1k
M. Castiglione Switzerland 26 2.8k 0.9× 2.5k 1.0× 879 0.6× 786 0.6× 517 0.4× 48 5.0k
Maureen Kavanah United States 17 3.2k 1.1× 3.5k 1.5× 3.7k 2.6× 1.8k 1.4× 651 0.6× 24 7.6k
H. Samuel Wieand United States 31 3.2k 1.1× 1.3k 0.5× 541 0.4× 1.2k 1.0× 1.3k 1.1× 53 5.0k
Nikolay Dimitrov Bulgaria 9 2.7k 0.9× 2.7k 1.1× 2.8k 1.9× 1.5k 1.2× 529 0.4× 44 5.9k
Geoffrey Falkson South Africa 43 3.4k 1.2× 2.0k 0.8× 910 0.6× 1.1k 0.8× 1.2k 1.0× 264 6.8k
J. Michael Dixon United Kingdom 33 2.4k 0.8× 3.2k 1.3× 1.1k 0.8× 1.6k 1.3× 1.2k 1.0× 82 5.0k
T.J. Powles United Kingdom 34 3.8k 1.3× 2.4k 1.0× 3.4k 2.4× 824 0.6× 371 0.3× 82 6.9k
Francesco Boccardo Italy 39 3.1k 1.1× 2.3k 1.0× 2.1k 1.5× 606 0.5× 619 0.5× 273 6.8k
Samuel Wieand United States 8 2.2k 0.8× 1.6k 0.7× 2.6k 1.8× 832 0.7× 316 0.3× 10 4.9k

Countries citing papers authored by B. Fisher

Since Specialization
Citations

This map shows the geographic impact of B. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Fisher more than expected).

Fields of papers citing papers by B. Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Fisher. The network helps show where B. Fisher may publish in the future.

Co-authorship network of co-authors of B. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of B. Fisher. A scholar is included among the top collaborators of B. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Fisher. B. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fisher, B.. (2011). Role of Science in the Treatment of Breast Cancer When Tumor Multicentricity is Present. JNCI Journal of the National Cancer Institute. 103(17). 1292–1298. 15 indexed citations
2.
Wolmark, Norman, et al.. (2001). Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18. JNCI Monographs. 2001(30). 96–102. 990 indexed citations breakdown →
3.
Fisher, B.. (1999). Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer. CA A Cancer Journal for Clinicians. 49(3). 159–177. 45 indexed citations
4.
Dignam, James J., et al.. (1999). Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17. Cancer. 86(3). 429–438. 380 indexed citations
6.
Ganz, Patricia A., Richard O. Day, John E. Ware, Carol Redmond, & B. Fisher. (1995). Base-Line Quality-of-Life Assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 87(18). 1372–1382. 181 indexed citations
7.
Fisher, B., Joseph P. Costantino, Carol Redmond, et al.. (1994). Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *. JNCI Journal of the National Cancer Institute. 86(7). 527–537. 959 indexed citations breakdown →
8.
Fisher, B.. (1992). The evolution of paradigms for the management of breast cancer: a personal perspective.. PubMed. 52(9). 2371–83. 102 indexed citations
9.
Fisher, B., Joe Costantino, Carol Redmond, et al.. (1989). A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors. New England Journal of Medicine. 320(8). 479–484. 1155 indexed citations breakdown →
10.
Fisher, B., Carol Redmond, N V Dimitrov, et al.. (1989). A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors. New England Journal of Medicine. 320(8). 473–478. 305 indexed citations
11.
Fisher, B., Norman Wolmark, Howard E. Rockette, et al.. (1988). Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011. JNCI Journal of the National Cancer Institute. 80(1). 21–29. 754 indexed citations breakdown →
12.
Wolmark, Norman, B. Fisher, Howard E. Rockette, et al.. (1988). Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011. JNCI Journal of the National Cancer Institute. 80(1). 30–36. 284 indexed citations
14.
Fisher, B.. (1986). Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation. Plastic & Reconstructive Surgery. 77(5). 862–863. 4 indexed citations
15.
Er, Fisher, Richard Sass, & B. Fisher. (1985). Biologic considerations regarding the one and two step procedures in the management of patients with invasive carcinoma of the breast.. PubMed. 161(3). 245–9. 9 indexed citations
16.
Wolmark, Norman, et al.. (1984). The relationship of depth of penetration and tumor size to the number of positive nodes in dukes C colorectal cancer. Cancer. 53(12). 2707–2712. 54 indexed citations
17.
Fisher, Eva & B. Fisher. (1970). Antilymphocyte Serum In Nephrotoxic Serum Nephritis. Experimental Biology and Medicine. 133(4). 1342–1345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026